MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

The comparison of curcumin and naringenin effects on motor function in rotenone model of Parkinson’s disease

S. Madiha (Karachi, Pakistan)

Meeting: 2023 International Congress

Abstract Number: 596

Keywords: Acetylcholine, Dopamine, Rotenone

Category: Drug-Induced Movement Disorders

Objective: The aim of the study was to compare the effects of curcumin and naringenin on rotenone-induced motor deficits and related neurochemical changes.

Background: Experimental data supports the use of phytochemicals as a preventive treatment for various Parkinson’s disease (PD) symptoms. Polyphenolic compounds such as curcumin and naringenin demonstrates neuroprotective action in neurodegenerative diseases. However, comparative role of natural products on PD-related features still unknown.

Method: In order to induce PD-like symptoms in Albino-Wistar rats, rotenone (1.5 mg/kg/day) was subcutaneously injected for 8 days. After 8 days of rotenone administration, rats received supplements of curcumin (100 mg/kg/day, p.o.) and naringenin (50 mg/kg/day, p.o.) for two weeks. The pole test, open field test, beam walking test, and footprint test were used to measure motor activity. Additionally, neurochemical estimation was also performed.

Results: Results of current investigation showed that curcumin and naringenin are more efficient in reducing the symptoms like PD induced by rotenone in rats. Curcumin significantly (p<0.01) modulated the neurotransmitter levels such as dopamine (DA), 5-hydroxytryptamine (5-HT), acetylcholine (ACh) and hence significantly (p<0.01) improved the motor activity, in rotenone toxicity. On the other side, naringenin exhibited more significant (p<0.01) effect on behavioral deficits and improved the motor coordination.

Conclusion: In conclusion, the findings suggest that a combination of particularly naringenin and curcumin supplements in daily life would be more effective in preventing and delaying the prevalence of PD.

References: [1] Zbarsky V, Datla KP, Parkar S, Rai DK, Aruoma OI, Dexter DT (2005). Neuroprotective properties of the natural phenolic antioxidants curcumin and naringenin but not quercetin and fisetinin a 6-OHDA model of Parkinson’s disease. Free Radic Res 39: 1119-1125. [2] Madiha S, and Haider S (2019). Curcumin restores rotenone induced depressive-like symptoms in animal model of neurotoxicity: assessment by social interaction test and sucrose preference test. Metabolic brain disease 34(1): 297-308. [3] Rice-Evans C (2001). Flavonoids antioxidants. Curr Med Chem 8: 797-807.2)

To cite this abstract in AMA style:

S. Madiha. The comparison of curcumin and naringenin effects on motor function in rotenone model of Parkinson’s disease [abstract]. Mov Disord. 2023; 38 (suppl 1). https://www.mdsabstracts.org/abstract/the-comparison-of-curcumin-and-naringenin-effects-on-motor-function-in-rotenone-model-of-parkinsons-disease/. Accessed May 13, 2025.
  • Tweet
  • Email
  • Print

« Back to 2023 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/the-comparison-of-curcumin-and-naringenin-effects-on-motor-function-in-rotenone-model-of-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Patients with Essential Tremor Live Longer than their Relatives
  • #23624 (not found)
  • The hardest symptoms that bother patients with Parkinson's disease
  • Three cases of early tremor in the course of Guillain-Barré Syndrome
  • The impact of gastric acid suppressants and antacids on levodopa plasma concentration in patients with Parkinson’s disease
  • To be or not to bupropion: a drug-induced parkinsonism?
  • The Role of MRI and DaTscan in Vascular Parkinsonism: A Case Report
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley